William Ciambrone is EVP of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 22,099 shares of SRPT, which is worth approximately $2.53 Million. The most recent transaction as insider was on Mar 07, 2022, when has been sold 8,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.1K
0% 3M change
0% 12M change
Total Value Held $2.53 Million

William Ciambrone Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2022
BUY
Grant, award, or other acquisition
-
8,000 Added 26.58%
22,099 Common Stock
Mar 04 2022
SELL
Payment of exercise price or tax liability
$91,872 $79.2 p/Share
1,160 Reduced 7.6%
14,099 Common Stock
Mar 03 2021
BUY
Grant, award, or other acquisition
-
15,000 Added 50.0%
15,000 Common Stock
WC

William Ciambrone

EVP
Cambridge, MA

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

News

Receive news related to Sarepta Therapeutics, Inc.

Track Activities on SRPT